{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:12:46Z","timestamp":1783944766525,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.anndiagpath.2026.152653","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:50:00Z","timestamp":1778050200000},"page":"152653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SEPT9 methylation as a potential biomarker for uncovering latent malignancy in flat urothelial lesions"],"prefix":"10.1016","volume":"84","author":[{"given":"Gengfang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152653_bb0005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152653_bb0010","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.euf.2019.03.012","article-title":"Carcinoma in situ of the urinary bladder: a systematic review of current knowledge regarding detection, treatment, and outcomes","volume":"6","author":"Subiela","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.anndiagpath.2026.152653_bb0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.humpath.2023.03.007","article-title":"Urothelial carcinoma in situ with \u201coverriding\u201d features can evade detection by mimicking umbrella cells","volume":"136","author":"Bahceci","year":"2023","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152653_bb0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/his.13762","article-title":"Precursor lesions of the urinary bladder","volume":"74","author":"McKenney","year":"2019","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152653_bb0025","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00000478-199904000-00009","article-title":"Natural history of urothelial dysplasia of the bladder","volume":"23","author":"Cheng","year":"1999","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2026.152653_bb0030","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1053\/hupa.2001.27109","article-title":"An objective morphologic parameter to aid in the diagnosis of flat urothelial carcinoma in situ","volume":"32","author":"Milord","year":"2001","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2026.152653_bb0035","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1309\/AJCPACNUDWEN9GN4","article-title":"Molecular and immunohistologic analyses cannot reliably solve diagnostic variation of flat intraepithelial lesions of the urinary bladder","volume":"134","author":"Murata","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152653_bb0040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5858\/arpa.2016-0411-OA","article-title":"CK20 and p53 immunohistochemical staining patterns in urinary bladder specimens with equivocal atypia","volume":"142","author":"Arias-Stella","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.anndiagpath.2026.152653_bb0045","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/jcp.2007.049684","article-title":"Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions","volume":"61","author":"Schwarz","year":"2008","journal-title":"J Clin Pathol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2026.152653_bb0050","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41379-022-01087-7","article-title":"Flat intraurothelial lesions of the urinary bladder-do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice","volume":"35","author":"Paner","year":"2022","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2026.152653_bb0055","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1111\/cas.14155","article-title":"Genomic profile of urine has high diagnostic sensitivity compared to cytology in non-invasive urothelial bladder cancer","volume":"110","author":"Hirotsu","year":"2019","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.anndiagpath.2026.152653_bb0060","doi-asserted-by":"crossref","first-page":"400","DOI":"10.5858\/arpa.2012-0136-OA","article-title":"Utility and diagnostic accuracy of ureteroscopic biopsy in upper tract urothelial carcinoma","volume":"137","author":"Vashistha","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152653_bb0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/path.1259","article-title":"Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses","volume":"199","author":"Obermann","year":"2003","journal-title":"J Pathol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2026.152653_bb0070","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/ijc.21958","article-title":"Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder","volume":"119","author":"van Oers","year":"2006","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152653_bb0075","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1186\/s12885-021-08653-3","article-title":"Interaction between DNMT3B and MYH11 via hypermethylation regulates gastric cancer progression","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.anndiagpath.2026.152653_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071653","article-title":"Methylation of SPARCL1 is associated with oncologic outcome of advanced upper urinary tract urothelial carcinoma","volume":"20","author":"Luo","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"21","key":"10.1016\/j.anndiagpath.2026.152653_bb0085","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMra023075","article-title":"Gene silencing in cancer in association with promoter hypermethylation","volume":"349","author":"Herman","year":"2003","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.anndiagpath.2026.152653_bb0090","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1158\/0008-5472.CAN-08-0142","article-title":"Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer","volume":"69","author":"Glockner","year":"2009","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152653_bb0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s13277-011-0302-2","article-title":"DNA methylation biomarker candidates for early detection of colon cancer","volume":"33","author":"Yi","year":"2012","journal-title":"Tumour Biol"},{"key":"10.1016\/j.anndiagpath.2026.152653_bb0100","doi-asserted-by":"crossref","DOI":"10.1007\/s00428-025-04317-w","article-title":"Methylated ARHGAP40 in renal cell carcinoma associated with tumor necrosis and grade: a potential biomarker for non-invasive early detection","author":"Wang","year":"2025","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2026.152653_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00247","article-title":"Diagnostic value of methylated Septin9 for colorectal cancer detection","volume":"8","author":"Xie","year":"2018","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2026.152653_bb0110","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/cac2.12478","article-title":"Combining methylated SEPTIN9 and RNF180 plasma markers for diagnosis and early detection of gastric cancer","volume":"43","author":"Nie","year":"2023","journal-title":"Cancer Commun (Lond)"},{"issue":"10","key":"10.1016\/j.anndiagpath.2026.152653_bb0115","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.hpb.2021.03.015","article-title":"Role of methylated septin 9 as an adjunct diagnostic and prognostic biomarker in hepatocellular carcinoma","volume":"23","author":"Bannaga","year":"2021","journal-title":"HPB (Oxford)"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152653_bb0120","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00432-018-02829-4","article-title":"A three-gene methylation marker panel for the nodal metastatic risk assessment of muscle-invasive bladder cancer","volume":"145","author":"Stubendorff","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152653_bb0125","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1186\/s12885-016-2748-5","article-title":"Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive\/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer","volume":"16","author":"Roperch","year":"2016","journal-title":"BMC Cancer"},{"issue":"30","key":"10.1016\/j.anndiagpath.2026.152653_bb0130","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1038\/s41388-019-0844-0","article-title":"Septin 9 isoforms promote tumorigenesis in mammary epithelial cells by increasing migration and ECM degradation through metalloproteinase secretion at focal adhesions","volume":"38","author":"Marcus","year":"2019","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152653_bb0135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13148-019-0719-9","article-title":"Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance","volume":"11","author":"Jiao","year":"2019","journal-title":"Clin Epigenetics"},{"issue":"21","key":"10.1016\/j.anndiagpath.2026.152653_bb0140","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.7150\/jca.34944","article-title":"DNA methylation biomarkers in stool for early screening of colorectal cancer","volume":"10","author":"Chen","year":"2019","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152653_bb0145","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13000-020-00984-2","article-title":"CK20 versus AMACR and p53 immunostains in evaluation of urothelial carcinoma in situ and reactive atypia","volume":"15","author":"Neal","year":"2020","journal-title":"Diagn Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152653_bb0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13148-022-01335-2","article-title":"BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patients","volume":"14","author":"Pharo","year":"2022","journal-title":"Clin Epigenetics"},{"issue":"10","key":"10.1016\/j.anndiagpath.2026.152653_bb0155","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1097\/JS9.0000000000000592","article-title":"Diagnostic and therapeutic effects of fluorescence cystoscopy and narrow-band imaging in bladder cancer: a systematic review and network meta-analysis","volume":"109","author":"Fan","year":"2023","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152653_bb0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ajpath.2022.09.013","article-title":"Use of artificial intelligence for the interpretable prediction of the pathologic diagnosis and molecular abnormalities of flat urothelial lesions","volume":"193","author":"Nishikawa","year":"2023","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152653_bb0165","first-page":"75","article-title":"Diagnosis of intraurothelial neoplasia. Interobserver variation and the value of individual histopathologic attributes","volume":"33","author":"Isfoss","year":"2011","journal-title":"Anal Quant Cytol Histol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2026.152653_bb0170","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/PAI.0000000000000401","article-title":"Flat urothelial lesions with atypia: interobserver concordance and added value of immunohistochemical profiling","volume":"26","author":"Lawless","year":"2018","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2026.152653_bb0175","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1309\/AJCPACNUDWEN9GN4","article-title":"Molecular and immunohistologic analyses cannot reliably solve diagnostic variation of flat intraepithelial lesions of the urinary bladder","volume":"134","author":"Murata","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152653_bb0180","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.eururo.2010.01.025","article-title":"Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations","volume":"57","author":"Witjes","year":"2010","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152653_bb0185","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.eururo.2004.07.012","article-title":"Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer","volume":"47","author":"Stoehr","year":"2005","journal-title":"Eur Urol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913426000493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913426000493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:50:11Z","timestamp":1783943411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913426000493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S1092913426000493"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152653","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SEPT9 methylation as a potential biomarker for uncovering latent malignancy in flat urothelial lesions","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152653"}}